{
  "data": {
    "id": "stat_DH5S9CTN3S7QD1VVEJB5WPVD3S",
    "url": "https://statorigin.org/stat/stat_DH5S9CTN3S7QD1VVEJB5WPVD3S",
    "indicator": {
      "slug": "ctgov-ibd-trial-starts-jak",
      "name": "Trial starts since 2023: JAK inhibitors",
      "definition": "Count of interventional studies naming JAK inhibitors as an intervention within interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified, started from 2023-01-01 to 2026-09-27."
    },
    "industry": [
      {
        "slug": "pharmaceuticals",
        "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
        "isic": "C21",
        "is_primary": true
      }
    ],
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "period": {
      "start": "2023-01-01",
      "end": "2026-09-27",
      "type": "range"
    },
    "value": 20,
    "value_text": "20 studies",
    "unit": "count",
    "currency": null,
    "scale": "1",
    "value_type": "actual",
    "source": {
      "org": "ClinicalTrials.gov (U.S. National Library of Medicine)",
      "org_short_name": "ClinicalTrials.gov",
      "org_url": "https://clinicaltrials.gov",
      "org_tier": 1,
      "document_title": "ClinicalTrials.gov study count: Interventional studies of JAK inhibitors (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27",
      "document_url": "https://clinicaltrials.gov/api/v2/studies?query.intr=upadacitinib%20OR%20tofacitinib%20OR%20filgotinib%20OR%20ritlecitinib%20OR%20ivarmacitinib&query.cond=%22ulcerative%20colitis%22%20OR%20%22Crohn%20disease%22%20OR%20%22Crohn%27s%20disease%22%20OR%20%22inflammatory%20bowel%20disease%22&filter.advanced=AREA%5BStudyType%5DINTERVENTIONAL%20AND%20%28AREA%5BInterventionType%5DDRUG%20OR%20AREA%5BInterventionType%5DBIOLOGICAL%29%20AND%20AREA%5BStartDate%5DRANGE%5B2023-01-01%2C2026-09-27%5D&countTotal=true&pageSize=1&fields=NCTId",
      "document_type": "dataset",
      "locator": "totalCount field of the API response. Query: Interventional studies of JAK inhibitors (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27.",
      "quote": "{\"totalCount\":20,\"studies\":[",
      "published_date": null,
      "accessed_at": "2026-09-27",
      "license": "public-domain",
      "url_status": "ok",
      "self_reported": false
    },
    "verification": "verified",
    "verified_by": "pipeline:ctgov-api-totalcount-verified",
    "verified_at": "2026-09-27T12:00:00.000Z",
    "confidence": 0.95,
    "is_secondhand": false,
    "supersedes": "stat_HQB6F7A4J0N3Q7DXN4S15MB1M9",
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "ClinicalTrials.gov (U.S. National Library of Medicine). (2026). ClinicalTrials.gov study count: Interventional studies of JAK inhibitors (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27. Retrieved September 27, 2026, from https://clinicaltrials.gov/api/v2/studies?query.intr=upadacitinib%20OR%20tofacitinib%20OR%20filgotinib%20OR%20ritlecitinib%20OR%20ivarmacitinib&query.cond=%22ulcerative%20colitis%22%20OR%20%22Crohn%20disease%22%20OR%20%22Crohn%27s%20disease%22%20OR%20%22inflammatory%20bowel%20disease%22&filter.advanced=AREA%5BStudyType%5DINTERVENTIONAL%20AND%20%28AREA%5BInterventionType%5DDRUG%20OR%20AREA%5BInterventionType%5DBIOLOGICAL%29%20AND%20AREA%5BStartDate%5DRANGE%5B2023-01-01%2C2026-09-27%5D&countTotal=true&pageSize=1&fields=NCTId. Via StatOrigin, https://statorigin.org/stat/stat_DH5S9CTN3S7QD1VVEJB5WPVD3S",
      "bibtex": "@misc{clinicaltrialsgo2026ctgovwpvd3s,\n  author       = {{ClinicalTrials.gov (U.S. National Library of Medicine)}},\n  title        = {ClinicalTrials.gov study count: Interventional studies of JAK inhibitors (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_DH5S9CTN3S7QD1VVEJB5WPVD3S},\n  note         = {Original source: https://clinicaltrials.gov/api/v2/studies?query.intr=upadacitinib\\%20OR\\%20tofacitinib\\%20OR\\%20filgotinib\\%20OR\\%20ritlecitinib\\%20OR\\%20ivarmacitinib\\&query.cond=\\%22ulcerative\\%20colitis\\%22\\%20OR\\%20\\%22Crohn\\%20disease\\%22\\%20OR\\%20\\%22Crohn\\%27s\\%20disease\\%22\\%20OR\\%20\\%22inflammatory\\%20bowel\\%20disease\\%22\\&filter.advanced=AREA\\%5BStudyType\\%5DINTERVENTIONAL\\%20AND\\%20\\%28AREA\\%5BInterventionType\\%5DDRUG\\%20OR\\%20AREA\\%5BInterventionType\\%5DBIOLOGICAL\\%29\\%20AND\\%20AREA\\%5BStartDate\\%5DRANGE\\%5B2023-01-01\\%2C2026-09-27\\%5D\\&countTotal=true\\&pageSize=1\\&fields=NCTId. Accessed September 27, 2026.}\n}"
    },
    "updated_at": "2026-09-27T01:11:36.992Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}